Literature DB >> 4853604

Pharmacokinetics of single and multiple doses of phenytoin in man.

L Lund, G Alvan, A Berlin, B Alexanderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4853604     DOI： 10.1007/bf00561319

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  25 in total

1.  Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin.

Authors:  F BUCHTHAL; O SVENSMARK; P J SCHILLER
Journal:  Arch Neurol       Date:  1960-06

2.  Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

Authors:  M M Reidenberg; I Odar-Cederlöf; C von Bahr; O Borgå; F Sjöqvist
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

3.  Dicoumarol-induced diphenylhydantoin intoxication.

Authors:  J M Hansen; M Kristensen; L Skovsted; L K Christensen
Journal:  Lancet       Date:  1966-07-30       Impact factor: 79.321

4.  Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.

Authors:  I Odar-Cederlöf; O Borgå
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

5.  Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.

Authors:  N Gerber; J G Wagner
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-05

6.  Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid--a comparison between a gas chromatographic and a spectrophotometric method.

Authors:  A Berlin; S Agurell; O Borgå; L Lund; F Sjöqvist
Journal:  Scand J Clin Lab Invest       Date:  1972-05       Impact factor: 1.713

7.  The effect of phenyramidol on the metabolism of diphenylhydantoin.

Authors:  H M Solomon; J J Schrogie
Journal:  Clin Pharmacol Ther       Date:  1967 Jul-Aug       Impact factor: 6.875

8.  Outbreak of anticonvulsant intoxication in an Australian city.

Authors:  J H Tyrer; M J Eadie; J M Sutherland; W D Hooper
Journal:  Br Med J       Date:  1970-10-31

9.  Depression of prahydroxylation of diphenylhydantoin by antituberculosis chemotherapy.

Authors:  H Kutt; W Winters; F H McDowell
Journal:  Neurology       Date:  1966-06       Impact factor: 9.910

10.  [The significance of cumulation and elimination for the determination of Phenytoin (diphenylhydantoin)].

Authors:  H Remmer; J Hirschmann; I Greiner
Journal:  Dtsch Med Wochenschr       Date:  1969-06-13       Impact factor: 0.628
View more
  16 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Effect of ethanol intake on phenytoin metabolism in volunteers.

Authors:  D Schmidt
Journal:  Experientia       Date:  1975-11-15

3.  Nonlinear assessment of phenytoin bioavailability.

Authors:  W J Jusko; J R Koup; G Alván
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

4.  The pharmacokinetics of acetanilide and of diphenylhydantoin sodium.

Authors:  J L Cunningham; M F Bullen; D A Evans
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

5.  Clinical significance of generic inequivalence of three different pharmaceutical preparations of phenytoin.

Authors:  L Lund
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

6.  Application of a simplified method to determine bioavailability of an oral dose of phenytoin.

Authors:  A L Davis; E J Begg; M C Kennedy; G G Graham
Journal:  J Pharmacokinet Biopharm       Date:  1993-04

7.  [Plasma concentrations after injection or infusion of phenytoin (author's transl)].

Authors:  D Schmidt; A Vogel
Journal:  Klin Wochenschr       Date:  1977-03-01

Review 8.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

9.  Phenytoin dosage predictions in paediatric patients.

Authors:  G J Yuen; P T Latimer; L C Littlefield; R W Mackey
Journal:  Clin Pharmacokinet       Date:  1989-04       Impact factor: 6.447

10.  Bioavailability of three phenytoin preparations in healthy subjects and in epileptics.

Authors:  B Rambeck; H E Boenigk; E Stenzel
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.